Brief: Suven Life Sciences Gets Product Patents In New Zealand And Sri Lanka
14/09/2018 06:56
Sept 14 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SAYS GETS PRODUCT PATENTS IN NEW ZEALAND AND SRI LANKA
* SUVEN LIFE SCIENCES -PATENTS FOR CHEMICAL ENTITY FOR
TREATMENT
OF DISORDERS FOR NEURODEGENERATIVE DISEASES; VALID THROUGH 2034
AND 2031 RESPECTIVELY
Source text - https://bit.ly/2Mryw2p
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees